Back
Aprea Therapeutics Quote, Financials, Valuation and Earnings
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aprea Therapeutics Price Quote
$2.60
Aprea Therapeutics Key Stats
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Day range:
$2.60 - $2.69
52-week range:
$2.25 - $8.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.55%
Volume:
13.9K
Avg. volume:
10.5K
1-year change:
-46%
Market cap:
$14.1M
Revenue:
$0
EPS:
$-3.03
How Much Does Aprea Therapeutics Make?
Data Unavailable
Is Aprea Therapeutics Growing As A Company?
Data Unavailable
Aprea Therapeutics Stock Price Performance
-
Did Aprea Therapeutics Stock Go Up Last Month?
Aprea Therapeutics share price went down by -25.71% last month -
Did APRE's Share Price Rise Over The Last Year?
APRE share price fell by -46% over the past 1 year
What Is Aprea Therapeutics 52-Week High & Low?
-
What Is Aprea Therapeutics’s 52-Week High Share Price?
Aprea Therapeutics has traded as high as $8.85 over the past 52 weeks -
What Is Aprea Therapeutics’s 52-Week Low Share Price?
Aprea Therapeutics has traded as low as $2.25 over the past 52 weeks
Aprea Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aprea Therapeutics?
-
How Much Debt Does Aprea Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aprea Therapeutics Have?
Cash and short term investments quarterly total is $28.7M -
What Is Aprea Therapeutics’s Book Value Per Share?
Book value per share is 4.71
Is Aprea Therapeutics Cash Flow Positive?
-
What Is APRE Cash Flow From Operations?
Cash flow from operations (TTM) is -$13.6M -
What Is Aprea Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $14.7M -
What Is Aprea Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$108.6K
Aprea Therapeutics Return On Invested Capital
Data Unavailable
Aprea Therapeutics Earnings Date & Stock Price
-
What Is Aprea Therapeutics's Stock Price Today?
A single share of APRE can be purchased today for 2.60 -
What Is Aprea Therapeutics’s Stock Symbol?
Aprea Therapeutics trades on the nasdaq under the ticker symbol: APRE -
When Is Aprea Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aprea Therapeutics is scheduled on November 8, 2024 -
When Is APRE's next ex-dividend date?
Aprea Therapeutics's next ex-dividend date is October 6, 2024 -
How To Buy Aprea Therapeutics Stock?
You can buy Aprea Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aprea Therapeutics Competitors
-
Who Are Aprea Therapeutics's Competitors?
Below is a list of companies who compete with Aprea Therapeutics or are related in some way:
Aprea Therapeutics Dividend Yield
-
What Is APRE Dividend Yield?
Aprea Therapeutics’s dividend yield currently is 0% -
What Is Aprea Therapeutics’s Payout Ratio?
Aprea Therapeutics’s payout ratio is 0% -
When Did Aprea Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 6, 2024 -
What Is Aprea Therapeutics’s Dividend Per Share?
Aprea Therapeutics pays a dividend of $0.00 per share
Aprea Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 4.13% |
| Revenue: | 0% | 1584.88% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 15.67 |
| Upside from Last Price: | 502.56% |